Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series.

Naqvi, Mohammad Faraz; Vo, Henry Hiep; Vining, David; Tsimberidou, Apostolia-Maria

Naqvi, Mohammad Faraz; Vo, Henry Hiep; Vining, David; Tsimberidou, Apostolia-Maria.

Afiliação

Naqvi MF; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vo HH; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vining D; Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tsimberidou AM; Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, The University of Texas MD Anderson Cancer Center, Unit 455, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Ther Adv Med Oncol ; 13: 17588359211001538, 2021.

Article em En | MEDLINE | ID: mdl-33995588

Palavras-chave

cell-free DNA; circulating tumor DNA; genomic profiling; personalized therapy; precision medicine; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google